182 related articles for article (PubMed ID: 33653306)
1. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.
Wong SK; Hamm J; Shokoohi A; McGahan CE; Ho C
BMC Cancer; 2021 Mar; 21(1):215. PubMed ID: 33653306
[TBL] [Abstract][Full Text] [Related]
2. Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy.
Moore S; Leung B; Wu J; Ho C
J Thorac Oncol; 2019 Aug; 14(8):1430-1439. PubMed ID: 31002953
[TBL] [Abstract][Full Text] [Related]
3. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
4. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
Fang P; He W; Gomez DR; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):748-757. PubMed ID: 28366580
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers.
Cone EB; Marchese M; Paciotti M; Nguyen DD; Nabi J; Cole AP; Molina G; Molina RL; Minami CA; Mucci LA; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Dec; 3(12):e2030072. PubMed ID: 33315115
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
7. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
[TBL] [Abstract][Full Text] [Related]
8. Underutilization of curative treatment among patients with non small cell lung cancer: experience from a tertiary care centre in India.
Malik PS; Malik A; Deo SV; Mohan A; Mohanti BK; Raina V
Asian Pac J Cancer Prev; 2014; 15(6):2875-8. PubMed ID: 24761917
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
10. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
[TBL] [Abstract][Full Text] [Related]
12. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
13. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
Wallington M; Saxon EB; Bomb M; Smittenaar R; Wickenden M; McPhail S; Rashbass J; Chao D; Dewar J; Talbot D; Peake M; Perren T; Wilson C; Dodwell D
Lancet Oncol; 2016 Sep; 17(9):1203-16. PubMed ID: 27599138
[TBL] [Abstract][Full Text] [Related]
14. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
15. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
16. Etiology, prevention, and treatment of breast, prostate, colorectal, and lung cancer.
Mandel JS; Oken M
Minn Med; 1998 May; 81(5):44-6, 71. PubMed ID: 9637858
[No Abstract] [Full Text] [Related]
17. Does intensive follow-up alter outcome in patients with advanced lung cancer?
Benamore R; Shepherd FA; Leighl N; Pintilie M; Patel M; Feld R; Herman S
J Thorac Oncol; 2007 Apr; 2(4):273-81. PubMed ID: 17409797
[TBL] [Abstract][Full Text] [Related]
18. Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
Meldgaard P; Kristensen M; Conte S; Kaae Andersen K; Jovanovic A; Meldgaard E
Acta Oncol; 2023 Dec; 62(12):1672-1679. PubMed ID: 37699061
[TBL] [Abstract][Full Text] [Related]
19. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.
Wanders R; Steevens J; Botterweck A; Dingemans AM; Reymen B; Baardwijk Av; Borger J; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
Eur J Cancer; 2011 Dec; 47(18):2691-7. PubMed ID: 21733675
[TBL] [Abstract][Full Text] [Related]
20. Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer.
Nielsen SS; He Y; Ayanian JZ; Gomez SL; Kahn KL; West DW; Keating NL
Cancer; 2010 Dec; 116(23):5497-506. PubMed ID: 20672356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]